WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that it will host a conference call at 8:30 am ET on Monday, October 11, 2010 to discuss the Company’s new collaboration announced this morning and its updated financial guidance for ImmunoGen’s fiscal year ending June 30, 2011.
